Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 10;18(1):113.
doi: 10.1186/s12984-021-00908-1.

A video game based hand grip system for measuring muscle force in children

Affiliations

A video game based hand grip system for measuring muscle force in children

Mark Gotthelf et al. J Neuroeng Rehabil. .

Abstract

Background: While new therapies are continuously introduced to treat muscular dystrophy, current assessment tests are challenging to quantify, cannot be used in non-ambulatory patients, or can de-motivate pediatric patients. We developed a simple, engaging, upper-limb assessment tool that measures muscle strength and fatigue in children, including children with muscular dystrophy. The device is a bio-feedback grip sensor that motivates children to complete maximal and fatiguing grip protocols through a game-based interface.

Methods: To determine if the new system provided the same maximum grip force as what is reported in the literature, data was collected from 311 participants without muscle disease (186 M, 125 F), ages 6 to 30, each of whom played the four minute grip game once. We compared maximum voluntary contraction at the start of the test to normative values reported in the literature using Welch's unequal variances t-tests. In addition, we collected data on a small number of participants with muscle disease to determine if the assessment system could be used by the target patient population.

Results: Of the 311 participants without muscle disease that started the test, all but one completed the game. The maximum voluntary contraction data, when categorized by age, matched literature values for hand grip force within an acceptable range. Grip forced increased with age and differed by gender, and most participants exhibited fatigue during the game, including a degradation in tracking ability as the game progressed. Of the 13 participants with muscle disease, all but one completed the game.

Conclusions: The study demonstrated the technical feasibility and validity of the new hand grip device, and indicated that the device can be used to assess muscle force and fatigue in longitudinal studies of children with muscular dystrophy.

Keywords: Game-playing; Muscle fatigue; Muscle force assessment; Muscular dystrophy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
a Hand-grip dynamometer and associated electronics interface box. b System in use at the 2018 Minnesota State Fair
Fig. 2
Fig. 2
a Screen shot of the calibration task from the Rocket Launch application. b Screen shot of the tracking task from the Rocket Launch application
Fig. 3
Fig. 3
Task interval time line used in the Rocket Launch game
Fig. 4
Fig. 4
Example of run data from a 9 year old male participant. Target is percent MVC0. MVC0, MVC1 and MVC2 indicate the three MVC tests during the game
Fig. 5
Fig. 5
MVC0 (mean+95%CI) of male participants (n=139, dark bars) compared to normative male data (light bars) from multiple sources [, , –54], grouped by 2 year age ranges from 6 to 19 and 5 year age ranges from 20-34. Significant differences marked by *(p<.05) and **(p<.01)
Fig. 6
Fig. 6
MVC0 (mean+95%CI) of female participants (n=98, dark bars) and normative female data (light bars) from multiple sources [, , –54], grouped by 2 year age ranges from 6-19 and 5 year age ranges from 20 to 34. Significant differences marked by *(p <. 05) and ** (p<.01)
Fig. 7
Fig. 7
Grip strength by age in a healthy population of males (n=139) and females (n=98) with trendlines for male (r2=0.67) and female (r2=0.46). The trendlines show that MVC increases with age for both genders
Fig. 8
Fig. 8
MVC % (mean+SD) during MVC0 (M=100.0, SD=0.0), MVC1 (M=80.2, SD=12.6) and MVC2 (M=76.2, SD=13.7) periods of gameplay in healthy population (N=237 for each group). There was a significant difference between groups, F(2,708)=335.8, p<.001 with post hoc comparisons using Bonferroni correction indicated that all three groups were significantly different from each other (***p<0.001)
Fig. 9
Fig. 9
RMS tracking error over the entire game by MVC0 in a healthy population (N=237). The two variables are not strongly correlated, r(235)=-0.22, p<0.001
Fig. 10
Fig. 10
RMS tracking error over the entire game by age in a healthy population (N=237). The two variables are not strongly correlated, r(235)=-0.22, p<0.001
Fig. 11
Fig. 11
Compares RMS tracking error (mean + SD) for the 1st and 2nd 40, 60 and 80% of MVC0 target periods in a non-impaired population (N=237 in each group). For the 40% MVC0 target, tracking was better in the second half of the test while for the 60 and 80% MVC0 targets, tracking was worse in the second half
Fig. 12
Fig. 12
Example of run data from a 20 year old male participant with Duchenne muscular dystrophy

References

    1. Mercuri E, Muntoni F. Muscular dystrophies. Lancet. 2013;381(9869):845–860. doi: 10.1016/S0140-6736(12)61897-2. - DOI - PubMed
    1. Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51(6):919–928. doi: 10.1016/0092-8674(87)90579-4. - DOI - PubMed
    1. Romitti PA, Zhu Y, Puzhankara S, James KA, Nabukera SK, Zamba GKD, Ciafaloni E, Cunniff C, Druschel CM, Mathews KD, Matthews DJ, Meaney FJ, Andrews JG, Caspers Conway KM, Fox DJ, Street N, Adams MM, Bolen J. Prevalence of duchenne and becker muscular dystrophies in the united states. Pediatrics. 2015;135(3):513–521. doi: 10.1542/peds.2014-2044. - DOI - PMC - PubMed
    1. MedlinePlus: Duchenne muscular dystrophy: MedlinePlus Medical Encyclopedia (2019). http://www.nlm.nih.gov/medlineplus/ency/article/000705.htm Accessed 2021-05-01
    1. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C. DMD Care Considerations Working Group: Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet. 2010;9(1):77–93. doi: 10.1016/S1474-4422(09)70271-6. - DOI - PubMed

Publication types

LinkOut - more resources